Expression of cancer testis antigens in thymic epithelial tumors

Melanoma-associated antigen-A and programmed death-ligand 1 expression are associated with advanced urothelial carcinoma

(2019) Izak Faiena et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

A mutation analysis of the EGFR pathway genes, RAS , EGFR , PIK 3 CA , AKT 1 , and BRAF , and TP 53 gene in thymic carcinoma and thymoma type A/B3

(2019) Tadashi Sakane et al.   HISTOPATHOLOGY

A comparative study of PD-L1 immunohistochemical assays with four reliable antibodies in thymic carcinoma

(2018) Tadashi Sakane et al.   Oncotarget

Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy

(2018) Aurélie Durgeau et al.   Frontiers in Immunology

PD-L1 reverses depigmentation in Pmel-1 vitiligo mice by increasing the abundance of Tregs in the skin

(2018) Xiao Miao et al.   Scientific Reports

Expression of cancer/testis antigens in salivary gland carcinomas with reference to MAGE-A and NY-ESO-1 expression in adenoid cystic carcinoma

(2017) Shintaro Beppu et al.   HISTOPATHOLOGY

Promoter hypomethylation of NY-ESO-1, association with clinicopathological features and PD-L1 expression in non-small cell lung cancer

(2017) Anderly C. Chüeh et al.   Oncotarget

The role of GAGE cancer/testis antigen in metastasis: the jury is still out

(2016) Morten Frier Gjerstorff et al.   BMC CANCER

MAGE-A family expression is correlated with poor survival of patients with lung adenocarcinoma: a retrospective clinical study based on tissue microarray

(2016) Meixiang Sang et al.   JOURNAL OF CLINICAL PATHOLOGY

MAGE-A is More Highly Expressed Than NY-ESO-1 in a Systematic Immunohistochemical Analysis of 3668 Cases

(2016) Sid P. Kerkar et al.   JOURNAL OF IMMUNOTHERAPY

Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial

(2016) Johan F Vansteenkiste et al.   LANCET ONCOLOGY

Survival of Lung Adenocarcinoma Patients Predicted from Expression of PD-L1, Galectin-9, and XAGE1 (GAGED2a) on Tumor Cells and Tumor-Infiltrating T Cells

(2016) Y. Ohue et al.   Cancer Immunology Research

PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients

(2016) Hye Ryun Kim et al.   Scientific Reports

The Impact of Thymoma Histotype on Prognosis in a Worldwide Database

(2015) Cleo-Aron Weis et al.   Journal of Thoracic Oncology

A Comprehensive Expression Analysis of Cancer Testis Antigens in Head and Neck Squamous Cell Carcinoma Revels MAGEA3/6 as a Marker for Recurrence

(2015) F. T. Zamuner et al.   MOLECULAR CANCER THERAPEUTICS

Expression of Cancer/Testis Antigens is Correlated with Improved Survival in Glioblastoma

(2015) Marcelo R.P. Freitas et al.   Oncotarget

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

(2014) R. Salgado et al.   ANNALS OF ONCOLOGY

ITMIG Consensus Statement on the Use of the WHO Histological Classification of Thymoma and Thymic Carcinoma: Refined Definitions, Histological Criteria, and Reporting

(2014) Alexander Marx et al.   Journal of Thoracic Oncology

Type AB thymoma is not a mixed tumor of type A and type B thymomas, but a distinct type of thymoma

(2014) Yukari Miki et al.   VIRCHOWS ARCHIV

Analysis of GAGE, NY-ESO-1 and SP17 cancer/testis antigen expression in early stage non-small cell lung carcinoma

(2013) Morten F Gjerstorff et al.   BMC CANCER

Cancer-Testis Antigen Expression in Digestive Tract Carcinomas: Frequent Expression in Esophageal Squamous Cell Carcinoma and Its Precursor Lesions

(2013) Y.-T. Chen et al.   Cancer Immunology Research

Expression of MAGE-A3, NY-ESO-1, LAGE-1 and PRAME in urothelial carcinoma

(2012) L Dyrskjøt et al.   BRITISH JOURNAL OF CANCER

The biology of cancer testis antigens: Putative function, regulation and therapeutic potential

(2011) Elisabetta Fratta et al.   Molecular Oncology

Epidemiology of Thymoma and Associated Malignancies

(2010) Eric A. Engels   Journal of Thoracic Oncology

Cancer/testis (CT) antigens: Potential targets for immunotherapy

(2009) Otavia L. Caballero et al.   CANCER SCIENCE

Structural basis for subversion of cellular control mechanisms by the adenoviral E1A oncoprotein

(2009) J. C. Ferreon et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

MAGE-C1/CT-7 expression in plasma cell myeloma: Sub-cellular localization impacts on clinical outcome

(2008) M. Tinguely et al.   CANCER SCIENCE

An overview of the GAGE cancer/testis antigen family with the inclusion of newly identified members

(2008) M. F. Gjerstorff et al.   TISSUE ANTIGENS